{
    "title": "Drug-free Workplace Act of 1998",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Drug-Free Workplace Act of 1998''.\n\nSEC. 2. FINDINGS; PURPOSES.\n\n    (a) Findings.--Congress finds that--\n            (1) 74 percent of adults who use illegal drugs are \n        employed;\n            (2) small business concerns employ over 50 percent of the \n        Nation's workforce;\n            (3) in more than 88 percent of families with children under \n        the age of 18, at least 1 parent is employed; and\n            (4) employees who use and abuse addictive substances \n        increase costs for businesses and risk the health and safety of \n        all employees because--\n                    (A) absenteeism is 66 percent higher among drug \n                users than individuals who do not use drugs;\n                    (B) health benefit utilization is 300 percent \n                higher among drug users than individuals who do not use \n                drugs;\n                    (C) 47 percent of workplace accidents are drug-\n                related;\n                    (D) disciplinary actions are 90 percent higher \n                among drug users than among individuals who do not use \n                drugs; and\n                    (E) employee turnover is significantly higher among \n                drug users than among individuals who do not use drugs.\n    (b) Purposes.--The purposes of this Act are to--\n            (1) educate small business concerns about the advantages of \n        a drug-free workplace;\n            (2) provide financial incentives and technical assistance \n        to enable small business concerns to create a drug-free \n        workplace; and\n            (3) assist working parents in keeping their children drug-\n        free.\n\nSEC. 3. SENSE OF CONGRESS.\n\n    It is the sense of Congress that--\n            (1) businesses should adopt drug-free workplace programs;\n            (2) States should consider incentives to encourage \n        businesses to adopt drug-free workplace programs;\n            (3) such incentives may include--\n                    (A) financial incentives, including--\n                            (i) a reduction in workers' compensation \n                        premiums;\n                            (ii) a reduction in unemployment insurance \n                        premiums; and\n                            (iii) tax deductions in an amount equal to \n                        the amount of expenditures for employee \n                        assistance programs, treatment, or drug \n                        testing; and\n                    (B) other incentives, such as the adoption of \n                liability limitations, as recommended by the \n                President's Commission on Model State Drug Laws.\n\nSEC. 4. DRUG-FREE WORKPLACE DEMONSTRATION PROGRAM.\n\n    The Small Business Act (15 U.S.C. 631 et seq.) is amended--\n            (1) by redesignating section 32 as section 33; and\n            (2) by inserting after section 31 the following:\n\n``SEC. 32. DRUG-FREE WORKPLACE DEMONSTRATION PROGRAM.\n\n    ``(a) Definitions.--In this section:\n            ``(1) Drug-free workplace program.--The term `drug-free \n        workplace program' means a program that includes--\n                    ``(A) a written policy, including a clear statement \n                of expectations for workplace behavior, prohibitions \n                against substances in the workplace, and the \n                consequences of violating those expectations and \n                prohibitions;\n                    ``(B) alcohol and drug abuse prevention training \n                for a total of not less than 2 hours for each employee, \n                and additional alcohol and drug abuse prevention \n                training for employees who are parents;\n                    ``(C) employee drug testing conducted by a drug \n                testing laboratory certified by the Substance Abuse and \n                Mental Health Services Administration, approved by the \n                Department of Health and Human Services under the \n                Clinical Laboratories Improvement Act of 1967 (42 \n                U.S.C. 263a), or approved by the College of American \n                Pathologists, and a review of each positive test result \n                by a licensed medical review officer;\n                    ``(D) employee access to an employee assistance \n                program, including assessment, referral, and short-term \n                problem resolution; and\n                    ``(E) continuing alcohol and drug abuse prevention \n                assistance.\n            ``(2) Eligible intermediary.--The term `eligible \n        intermediary' means an organization--\n                    ``(A) that is described in paragraph (3) or (6) of \n                section 501(c) of the Internal Revenue Code of 1986 \n                that is exempt from taxation under section 5(a) of such \n                Code, or a program of any such organization; or\n                    ``(B) that provides services to any organization \n                described in subparagraph (A);\n                    ``(C) that has not less than 2 years of experience \n                in carrying out drug-free workplace programs or in \n                providing assistance and services to small business \n                concerns;\n                    ``(D) that has a drug-free workplace policy in \n                effect;\n                    ``(E) that is located in a State, the District of \n                Columbia, or a territory of the United States; and\n                    ``(F) the purpose of which is--\n                            ``(i) to develop comprehensive drug-free \n                        workplace programs or to supply drug-free \n                        workplace services; or\n                            ``(ii) to provide other forms of assistance \n                        and services to small business concerns.\n            ``(3) Employee.--The term `employee' includes any--\n                    ``(A) supervisor;\n                    ``(B) manager;\n                    ``(C) officer of a small business concern who is \n                active in management of the concern; and\n                    ``(D) owner of a small business concern who is \n                active in management of the concern.\n    ``(b) Establishment.--There is established a drug-free workplace \ndemonstration program, under which the Administrator may make grants \nto, or enter into cooperative agreements or contracts with, eligible \nintermediaries for the purpose of providing financial and technical \nassistance to small business concerns seeking to establish a drug-free \nworkplace program.\n    ``(c) Evaluation and Coordination.--Not later than 1 year after the \ndate of enactment of the Drug-Free Workplace Act of 1998, the \nAdministrator, in coordination with the Secretary of Labor, the \nSecretary of Health and Human Services, and the Director of the Office \nof National Drug Control Policy, shall--\n            ``(1) evaluate the drug-free workplace programs established \n        with assistance made available under this section; and\n            ``(2) submit to Congress a report describing the results of \n        the evaluation under paragraph (1).\n    ``(d) Contract Authority.--In carrying out this section, the \nAdministrator may--\n            ``(1) contract with public and private entities to provide \n        assistance related to carrying out the program under this \n        section; and\n            ``(2) compensate those entities for provision of that \n        assistance.\n    ``(e) Construction.--Nothing in this section may be construed to \nrequire an employer who attends a program offered by an intermediary to \ncontract for any service offered by the intermediary.\n    ``(f) Authorization.--There is authorized to be appropriated to \ncarry out this section, $10,000,000 for fiscal year 1999. Amounts made \navailable under this subsection shall remain available until \nexpended.''.\n\nSEC. 5. SMALL BUSINESS DEVELOPMENT CENTERS.\n\n    Section 21(c)(3) of the Small Business Act (15 U.S.C. 648(c)(3)) is \namended--\n            (1) in subparagraph (R), by striking ``and'' at the end;\n            (2) in subparagraph (S), by striking the period at the end \n        and inserting ``; and''; and\n            (3) by adding at the end the following:\n            ``(T) providing information and assistance to small \n        business concerns with respect to establishing drug-free \n        workplace programs (as defined in section 32(a)).''."
}